These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 19932428)

  • 1. Thrombopoietin and platelet production in chronic immune thrombocytopenia.
    Kuter DJ; Gernsheimer TB
    Hematol Oncol Clin North Am; 2009 Dec; 23(6):1193-211. PubMed ID: 19932428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating thrombopoietin level in chronic immune thrombocytopenic purpura.
    Kosugi S; Kurata Y; Tomiyama Y; Tahara T; Kato T; Tadokoro S; Shiraga M; Honda S; Kanakura Y; Matsuzawa Y
    Br J Haematol; 1996 Jun; 93(3):704-6. PubMed ID: 8652398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pathophysiology of ITP revisited: ineffective thrombopoiesis and the emerging role of thrombopoietin receptor agonists in the management of chronic immune thrombocytopenic purpura.
    Gernsheimer TB
    Hematology Am Soc Hematol Educ Program; 2008; ():219-26. PubMed ID: 19074086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombopoietin receptor agonist (TPO-RA) treatment raises platelet counts and reduces anti-platelet antibody levels in mice with immune thrombocytopenia (ITP).
    Kapur R; Aslam R; Speck ER; Rebetz JM; Semple JW
    Platelets; 2020; 31(3):399-402. PubMed ID: 31146647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Romiplostim in chronic immune thrombocytopenic purpura.
    Cersosimo RJ
    Clin Ther; 2009 Sep; 31(9):1887-907. PubMed ID: 19843480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathophysiology and management of primary immune thrombocytopenia.
    Kashiwagi H; Tomiyama Y
    Int J Hematol; 2013 Jul; 98(1):24-33. PubMed ID: 23702914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The potential role of thrombopoietin in idiopathic thrombocytopenic purpura.
    von dem Borne A; Folman C; van den Oudenrijn S; Linthorst G; de Jong S; de Haas M
    Blood Rev; 2002 Mar; 16(1):57-9. PubMed ID: 11913997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of serum thrombopoietin levels by platelets and megakaryocytes in patients with aplastic anaemia and idiopathic thrombocytopenic purpura.
    Ichikawa N; Ishida F; Shimodaira S; Tahara T; Kato T; Kitano K
    Thromb Haemost; 1996 Aug; 76(2):156-60. PubMed ID: 8865522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombopoietin mimetic agents in the management of immune thrombocytopenic purpura.
    Newland A
    Semin Hematol; 2007 Oct; 44(4 Suppl 5):S35-45. PubMed ID: 18096471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased thrombopoietin levels in idiopathic thrombocytopenic purpura patients with a poor response to steroid therapy.
    Sakane Y; Wada H; Kazuyo H; Shimura M; Nakasaki T; Katayama N; Nishikawa M; Deguchi K; Mori Y; Mori Y; Shiku H; Tahara T; Kato T
    Blood Coagul Fibrinolysis; 1998 Jun; 9(4):315-21. PubMed ID: 9690802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum thrombopoietin (TPO) levels in patients with amegakaryocytic thrombocytopenia are much higher than those with immune thrombocytopenic purpura.
    Mukai HY; Kojima H; Todokoro K; Tahara T; Kato T; Hasegawa Y; Kobayashi T; Ninomiya H; Nagasawa T; Abe T
    Thromb Haemost; 1996 Nov; 76(5):675-8. PubMed ID: 8950771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma thrombopoietin levels in patients with aplastic anemia and idiopathic thrombocytopenic purpura.
    Gu J; Lu L; Xu R; Chen X
    Chin Med J (Engl); 2002 Jul; 115(7):983-6. PubMed ID: 12150725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic idiopathic thrombocytopenic purpura: mechanisms of pathogenesis.
    Gernsheimer T
    Oncologist; 2009 Jan; 14(1):12-21. PubMed ID: 19144680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human thrombopoietin levels are high when thrombocytopenia is due to megakaryocyte deficiency and low when due to increased platelet destruction.
    Emmons RV; Reid DM; Cohen RL; Meng G; Young NS; Dunbar CE; Shulman NR
    Blood; 1996 May; 87(10):4068-71. PubMed ID: 8639762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of thrombopoietin-receptor agonists on circulating cytokine and chemokine levels in patients with primary immune thrombocytopenia (ITP).
    Gudbrandsdottir S; Ghanima W; Nielsen CH; Feng X; Hasselbalch HC; Bussel J
    Platelets; 2017 Jul; 28(5):478-483. PubMed ID: 27819522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum thrombopoietin levels in relation to disease status in patients with immune thrombocytopenic purpura.
    Kappers-Klunne MC; de Haan M; Struijk PC; van Vliet HH
    Br J Haematol; 2001 Dec; 115(4):1004-6. PubMed ID: 11843841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biology and chemistry of thrombopoietic agents.
    Kuter DJ
    Semin Hematol; 2010 Jul; 47(3):243-8. PubMed ID: 20620435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined thrombopoietin and platelet response to altitude in a patient with autoimmune thrombocytopenia.
    Krafft A; Huch R; Hartmann S; Breymann C
    Thromb Haemost; 2004 Mar; 91(3):626-7. PubMed ID: 15025089
    [No Abstract]   [Full Text] [Related]  

  • 19. Increased serum levels of thrombopoietin in patients with thrombotic thrombocytopenic purpura, idiopathic thrombocytopenic purpura, or disseminated intravascular coagulation.
    Hiyoyama K; Wada H; Shimura M; Nakasaki T; Katayama N; Nishikawa M; Shiku H; Tahara T; Kato T
    Blood Coagul Fibrinolysis; 1997 Sep; 8(6):345-9. PubMed ID: 9351524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Differences of Serum Thrombopoietin Levels Between Acquired Aplastic Anemia and Immune Thrombocytopenia in Pediatric Patients.
    Chen H; Ma J; Ouyang J; Fu L; Ma J; Yao J; Wu R; Chen Z
    J Pediatr Hematol Oncol; 2024 Aug; 46(6):281-286. PubMed ID: 38857156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.